ISO 11737-2:2019
Sterilization of health care products — Microbiological methods — Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process
Sterilization of health care products — Microbiological methods — Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process
- Статус документа:
- Действующий
- Формат:
- Электронный (PDF)
- Количество страниц:
- 16
- Дата публикации:
- 2 декабря 2019 г.
- Издание:
- ISO IS 11737 edition 3 version 1
- ICS:
- 07.100.10
1.1 This document specifies the general criteria for tests of sterility on medical devices that have been exposed to a treatment with the sterilizing agent which has been reduced relative to that anticipated to be used in routine sterilization processing. These tests are intended to be performed when defining, validating or maintaining a sterilization process. 1.2 This document is not applicable to: a) sterility testing for routine release of product that has been subjected to a sterilization process, b) performing a test for sterility (see 3.12), NOTE 1 The performance of a) or b) is not a requirement of ISO 11135, ISO 11137-1, ISO 11137-2, ISO 14160, ISO 14937, ISO 17665-1 or ISO 20857. c) test of sterility or test for sterility for demonstration of product shelf life, stability and/or package integrity, and d) culturing of biological indicators or inoculated products. NOTE 2 Guidance on culturing biological indicators is included in ISO 11138-7.
Abstract
Overview
ISO 11737-2:2019 - "Sterilization of health care products - Microbiological methods - Part 2" defines the criteria and practical guidance for tests of sterility used during the definition, validation and maintenance of a sterilization process. It applies to medical devices (health care products) that have been exposed to a reduced or fractional treatment with a sterilizing agent (verification dose), not to routine release sterility testing of fully processed product. The standard emphasizes method suitability, sample handling, and controlled test conditions to generate meaningful microbiological data for sterilization validation.
Key Topics and Requirements
- Scope and exclusions: Intended for tests of sterility performed after fractional exposure; not applicable to routine release testing, sterility tests for shelf‑life or package integrity, or culturing biological indicators (ISO 11138‑7 covers those).
- Sample selection and SIPs: Defines selection of product and the concept of a Sample Item Portion (SIP) - specified parts of the product to be tested. Requirements stress minimizing time between manufacture and exposure, and appropriate packaging of SIPs.
- Method suitability (bacteriostasis/fungistasis): Procedures to assess and demonstrate that the chosen microbiological method and culture conditions allow microbial recovery and growth, including dealing with inhibitory substances and providing rationale if full removal isn’t feasible.
- Testing conditions: Guidance on performing tests in a controlled environment, including immersion of samples in culture media where feasible, and procedures for identifying positive growth.
- Maintenance and reassessment: Periodic demonstration of ongoing method suitability to detect gradual changes over time; responsibilities and record controls for validation, routine control and documentation (Annex B).
- Practical guidance: Annex A offers technique-level guidance and considerations for interpreting sterility test results when defining or requalifying sterilization processes.
Applications and Users
ISO 11737-2:2019 is used by:
- Medical device manufacturers conducting sterilization process development and validation
- Contract laboratories performing microbiological testing for sterilization validation
- Quality assurance/quality control teams managing sterilization requalification and process maintenance
- Regulatory and compliance professionals demonstrating scientifically sound sterilization evidence
Practical applications include establishing radiation doses, confirming cycles for terminal sterilization, and evaluating product bioburden under reduced-exposure conditions.
Related Standards
- ISO 11135, ISO 11137 (radiation sterilization series), ISO 17665-1, ISO 14937, ISO 14160, ISO 20857 - standards for sterilization process development and validation
- ISO 11138-7 - guidance on culturing biological indicators
- ISO 13485 - quality management system considerations for medical devices
Keywords: ISO 11737-2:2019, tests of sterility, sterilization process validation, microbiological methods, sample item portion (SIP), method suitability, bioburden, medical device sterilization.
Технические детали
- Технический комитет
- ISO/TC 198 - Sterilization of health care products
- SKU
- ISO 11737-2:2019
Похожие стандарты
Стандарты, упомянутые в описании
BS EN ISO 11138-7:2019
ДействующийSterilization of health care products. Biological indicators. Guidance for the selection, use and interpretat…
ISO 11135:2014
ДействующийSterilization of health-care products — Ethylene oxide — Requirements for the development, validation and rou…
Overview ISO 11135:2014 - Sterilization of health‑care products - Ethylene oxide specifies the requirements for the development, validation and routine control of an ethylene oxide (EO) sterilization…
ISO 11137-2:2013
ДействующийSterilization of health care products — Radiation — Part 2: Establishing the sterilization dose
Overview ISO 11137-2:2013 - “Sterilization of health care products - Radiation - Part 2: Establishing the sterilization dose” specifies validated methods to determine the minimum radiation dose requi…